Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 5,562,000 | 5,292,800 | 5,047,000 | 5,204,400 | 5,209,500 |
| Cost of Goods | 1,051,900 | 947,400 | 816,400 | 909,300 | 1,155,200 |
| Gross Profit | 4,510,100 | 4,345,400 | 4,230,600 | 4,295,101 | 4,054,300 |
| Operating Expenses | 2,824,800 | 2,749,000 | 2,476,900 | 7,471,600 | 2,630,400 |
| Operating Income | 1,686,200 | 1,596,800 | 1,754,100 | -3,176,200 | 1,424,100 |
| Other Income | -616,700 | -129,100 | -70,700 | -161,200 | -1,656,900 |
| Pre-tax Income | 1,069,500 | 1,467,700 | 1,683,400 | -3,337,400 | -232,800 |
| Income Tax | 127,700 | 309,200 | 370,300 | 292,000 | 232,800 |
| Net Income Continuous | 941,800 | 1,158,500 | 1,313,100 | -3,629,400 | -465,600 |
| Net Income | $941,800 | $1,158,500 | $1,313,100 | $-3,629,400 | $-465,600 |
| EPS Basic Total Ops | 0.86 | 1.06 | 1.20 | -3.31 | -0.43 |
| EPS Basic Continuous Ops | 0.86 | 1.06 | 1.20 | -3.32 | -0.43 |
| EPS Diluted Total Ops | 0.86 | 1.06 | 1.20 | -3.31 | -0.43 |
| EPS Diluted Continuous Ops | 0.86 | 1.06 | 1.20 | -3.32 | -0.43 |
| EBITDA(a) | $1,995,900 | $1,902,800 | $2,060,400 | $-2,895,900 | $1,707,400 |